Eli Lilly and Company (SWX:LLY)
Switzerland · Delayed Price · Currency is CHF 840.00
0.00 (0.00%)
At close: Dec 19, 2025
Eli Lilly and Company Employees
Eli Lilly and Company had 47,000 employees as of December 31, 2024. The number of employees increased by 4,000 or 9.30% compared to the previous year.
Employees
47,000
Change (1Y)
4,000
Growth (1Y)
9.30%
Revenue / Employee
1.01M CHF
Profits / Employee
312.37K CHF
Market Cap
763.15B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 47,000 | 4,000 | 9.30% |
| Dec 31, 2023 | 43,000 | 4,000 | 10.26% |
| Dec 31, 2022 | 39,000 | 4,000 | 11.43% |
| Dec 31, 2021 | 35,000 | 0 | - |
| Dec 31, 2020 | 35,000 | 1,375 | 4.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Roche Holding AG | 103,249 |
| Novartis AG | 75,883 |
| Alcon | 25,599 |
| Sandoz Group AG | 22,049 |
| Lonza Group AG | 18,944 |
| Sonova Holding AG | 18,366 |
| Straumann Holding AG | 11,815 |
| Galenica AG | 7,971 |
Eli Lilly and Company News
- 2 days ago - Better Buy in 2026: UnitedHealth Group or Eli Lilly? - The Motley Fool
- 2 days ago - Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know - Nasdaq
- 2 days ago - Obesity pill race heats up - CNBC
- 2 days ago - Eli Lilly (LLY) Reports Promising Weight Maintenance Results for Orforglipron - GuruFocus
- 2 days ago - Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market. - The Motley Fool
- 2 days ago - Why Eli Lilly shares should be higher — plus, our wishlist for Nike's earnings - CNBC
- 2 days ago - Lose Weight on Zepbound, Keep It Off With Eli Lilly's New Pill? Data Say That Works. - Barrons
- 2 days ago - Eli Lilly (LLY) Reports Positive Phase 3 Trial Results, Impact on Obesity Treatment - GuruFocus